Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Fufang Ejiao Jiang for cancer-related fatigue
CTR20252770Phase 2Active
- Sponsor
- Dong-E-E-Jiao
- Start
- Nov 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Fufang E'jiao Jiang in cancer-related fatigue (CRF), sponsored by Dong-E-E-Jiao. Started Nov 2025; status: active.
02
Drugs
Fufang E'jiao Jiang
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on CTR20252770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252770.